Geroscience

Journal of Tissue Engineering and Regenerative Medicine Publishes Peer Reviewed Research Paper Establishing ProtoKinetix AAGP® Enhanced Stem Cell Vision Restoration

Retrieved on: 
Wednesday, April 7, 2021
Research, General Health, Philanthropy, Technology, Healthcare reform, State, Local, Other Policy Issues, Foundation, Science, Homeland security, Nanotechnology, Health, Public policy, Government, Branches of biology, Biology, Life sciences, Stem cells, Biotechnology, Emerging technologies, Regenerative biomedicine, Regenerative medicine, Tissue engineering, Retina, Progenitor cell, Geroscience

The paper has been published by the prestigious Journal of Tissue Engineering and Regenerative Medicine.

Key Points: 
  • The paper has been published by the prestigious Journal of Tissue Engineering and Regenerative Medicine.
  • The focus of this journal is therapeutic approaches which combine stem/progenitor cells with bioactive agents to restore, maintain, or improve tissue or organ function.
  • Vision loss due to degeneration of the retina, most commonly the macula, commonly appears with aging, comorbid cardiovascular conditions, genetics, or other exposures.
  • A panel member of the California Institute of Regenerative Medicine & Canadian Institutes of Health Research.

SRW Founder Unlocks Inner Youthfulness By “Harnessing the Nine Hallmarks of Aging”

Retrieved on: 
Tuesday, March 23, 2021
Gerontology, Demography, Old age, Ageing, Geroscience, Senescence, Theories of ageing

Its the reason why Greg Macpherson, pharmacist and author of the new book, Harnessing the Nine Hallmarks of Aging, says understanding aging at a cellular level gives you an advantage.

Key Points: 
  • Its the reason why Greg Macpherson, pharmacist and author of the new book, Harnessing the Nine Hallmarks of Aging, says understanding aging at a cellular level gives you an advantage.
  • In the absence of a unified theory on aging, about a decade ago, scientists defined the underlying aging process as the nine hallmarks of aging.
  • They developed a consensus model, noting what each hallmark of aging should exhibit during normal aging, and in cell models, if you aggravate it you see accelerated aging and if you make it better it slows the aging process.
  • More on SRW at: www.scienceresearchwellness.com ; order, Harnessing the Nine Hallmarks of Aging at: www.theninehallmarksofaging.com .

AgeX Announces Preprint Article Relating to Regeneration, Aging, and Cancer

Retrieved on: 
Friday, March 12, 2021
Health, Genetics, Clinical trials, Research, Science, Pharmaceutical, Biotechnology, Gerontology, Branches of biology, Life extensionists, Biology, Michael D. West, AgeX Therapeutics, Healing, Regeneration, Cancer, Geroscience

AgeX Therapeutics , Inc. (AgeX; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today the online publication of data relating to regeneration, aging, and cancer in bioRxiv.

Key Points: 
  • AgeX Therapeutics , Inc. (AgeX; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today the online publication of data relating to regeneration, aging, and cancer in bioRxiv.
  • The paper titled Differential Expression of , , and Protocadherin Isoforms During Differentiation, Aging, and Cancer presents for the first time data relating to mechanisms cells may use in the process of regeneration.
  • It also provides evidence that the family of genes may be involved in a wide array of human cancers.
  • We believe these results have significant importance for researchers working not only in the field of aging research, but the field of cancer research as well, said Michael D. West, PhD, CEO of AgeX.

Prominent Healthy Aging Researcher Brian Kennedy, Ph.D., To Address Natural Health Industry On Impact Of Personal Nutrition To Reduce Biological Age

Retrieved on: 
Tuesday, February 23, 2021
Branches of biology, Gerontology, Geroscience, Demography, Ageing, Life extension, Epigenetics

Kennedy was invited to address industry leaders to discuss how healthy-aging interventions, personalized nutrition, and tracking tests are demonstrating to consumers the importance of supplementing diets for optimal cellular health and healthy aging.

Key Points: 
  • Kennedy was invited to address industry leaders to discuss how healthy-aging interventions, personalized nutrition, and tracking tests are demonstrating to consumers the importance of supplementing diets for optimal cellular health and healthy aging.
  • He will also discuss recent research that led to the development of Rejuvant LifeTabs, a dietary supplement designed for healthy aging.
  • Tom Weldon, the CEO and Founder of Ponce De Leon Health, remarked, "We're very pleased that news of our research linking personal nutrition to healthy aging, is making headlines.
  • Rejuvant helps you establish your biological age baseline, and gives you the ability to test reductions in epigenetic aging while taking Rejuvant over time.

CEO of Longeveron Inc. to Present at the Intercontinental Summit on Aging & Gerontology

Retrieved on: 
Friday, February 19, 2021
Academic disciplines, Demography, Gerontology, Life extension, Ageing, Geroscience, The Journals of Gerontology, USC Davis School of Gerontology

He will discuss Longeverons ongoing clinical research program in Aging Frailty and Alzheimers disease, in addition to the regenerative medicine investigational clinical research field in general for diseases and conditions associated with aging.

Key Points: 
  • He will discuss Longeverons ongoing clinical research program in Aging Frailty and Alzheimers disease, in addition to the regenerative medicine investigational clinical research field in general for diseases and conditions associated with aging.
  • The Intercontinental Summit on Aging & Gerontology is hosted by the Sciinov Group and helps participants from universities and institutions to network with world-class scientists.
  • This all-day online event unites researchers, scientists, and academicians to discuss and share knowledge in the emerging field of Aging & Gerontology.
  • Longeveron is a clinical stage biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions.

New Research on the Science of Cellular Decline Presented at The Gerontological Society of America 2020 Annual Scientific Meeting

Retrieved on: 
Tuesday, December 15, 2020
Mitochondria, Geroscience, Gerontological Society of America, Mitochondrion, Branches of biology, Academic journals

BRIDGEWATER, N.J., Dec. 15, 2020 /PRNewswire/ --The Gerontological Society of America (GSA) 2020 Annual Scientific Meeting, held November 4-7, 2020, unveiled promising research on cellular decline and the role of cellular nutrients to support mitochondrial health during aging.

Key Points: 
  • BRIDGEWATER, N.J., Dec. 15, 2020 /PRNewswire/ --The Gerontological Society of America (GSA) 2020 Annual Scientific Meeting, held November 4-7, 2020, unveiled promising research on cellular decline and the role of cellular nutrients to support mitochondrial health during aging.
  • Notably, research shows that cellular nutrients can play a role in mitochondrial health after middle age.
  • A growing body of evidence reinforces the importance of cellular health, and these scientific advancements continue to drive innovation in Cellular Nutrition.
  • According to an interdisciplinary panel of international experts, AACD refers to the cellular hallmarks of accelerated aging and their clinical expression.

2020 Rhode Island Healthy Aging Data Report Shows Older Population is Growing and More Diverse

Retrieved on: 
Tuesday, December 8, 2020
Articles, Regions of the United States, Branches of biology, Gerontology, Medical terminology, Health, Personal life, RHODE ISLAND, Chronic condition, Geroscience, Hypertension, Obesity

"This report helps us identify important patterns of health behaviors, resources, disease and disparities in the way Rhode Islanders are aging," said Catherine Taylor, executive director at Age Friendly Rhode Island.

Key Points: 
  • "This report helps us identify important patterns of health behaviors, resources, disease and disparities in the way Rhode Islanders are aging," said Catherine Taylor, executive director at Age Friendly Rhode Island.
  • The 2020 Rhode Island Healthy Aging Data Report can inform community-level decisions for years to come to better support the aging populations in our state."
  • The 2020 Rhode Island Healthy Aging Data Report allows readers to compare41 communities within the state onhealthyagingindicators from chronic conditions like hypertension, diabetes and obesity tohealthyagingbehaviors like diet, exercise and immunizations.
  • To read the 2020 Rhode Island Healthy Aging Data Report and access the digital tools, visit www.healthyagingdatareports.org/rhode-island .

IsoPlexis to Present at Evercore ISI's 3rd Annual HealthCONx Conference on December 2, 2020

Retrieved on: 
Wednesday, November 25, 2020
Branches of biology, Clinical medicine, Medicine, Biomarkers, Omics, Proteomics, Immunotherapy, Geroscience

BRANFORD,Conn., Nov. 25, 2020 /PRNewswire/ --IsoPlexis, the leader in single-cell functional proteomics, announced today that Chief Executive Officer and Co-Founder, Sean Mackay, will present at Evercore ISI's 3rd Annual HealthCONx Conference on Wednesday, December 2nd at 9:40 a.m.

Key Points: 
  • BRANFORD,Conn., Nov. 25, 2020 /PRNewswire/ --IsoPlexis, the leader in single-cell functional proteomics, announced today that Chief Executive Officer and Co-Founder, Sean Mackay, will present at Evercore ISI's 3rd Annual HealthCONx Conference on Wednesday, December 2nd at 9:40 a.m.
  • IsoPlexis( www.isoplexis.com ) is dedicated to accelerating the fight against cancer and a range of the world's toughest diseases with its uniquely correlative, award-winning, single-cell proteomics systems.
  • By revealing unique immune biomarkers in small subsets of cells, we are advancing immunotherapies and targeted therapies to a more highly precise and personalized stage.
  • Our award winning integrated systems are used globally to advance the field of immune biology and biomarkers as we generate solutions to overcome the challenges of complex diseases.

CohBar’s CEO to Participate on the Emerging Companies Panel at the Targeting Metabesity Conference

Retrieved on: 
Thursday, October 8, 2020
Insilico Medicine, Geroscience, Healthspan, Academic journals, Periodicals, Publications

The Emerging Companies panelists will discuss approaches to accelerating the translation of emerging GeroScience into gains in public health by preventing or delaying chronic diseases and extending healthspan.

Key Points: 
  • The Emerging Companies panelists will discuss approaches to accelerating the translation of emerging GeroScience into gains in public health by preventing or delaying chronic diseases and extending healthspan.
  • Mr. Engle will be joined by biotechnology company leaders Ben Gibson, CEO of Pano Therapeutics; Ashish Nimgaonkar, CEO of Glyscend; Hanadie Yousef, Co-Founder and CEO of Juvena Therapeutics; and Alex Zhavoronkov, Chief Longevity Officer at Deep Longevity and CEO of InSilico Medicine on the panel.
  • The panel will be moderated by Ed Saltzman, Executive Chairman of Cello Health BioConsulting, previously Defined Health.
  • During the conference, a corporate overview of CohBars mitochondrial peptide technology platform will be presented by Mr. Engle on October 15 at 12:00pm ET.

Aging-US Releases "From Causes of Aging to Death from COVID-19"

Retrieved on: 
Wednesday, October 7, 2020
Gerontology, Demography, Ageing, Aging-associated diseases, Life extension, Evolution of ageing, Geroscience, Aging, Coronavirus disease, Death

ORCHARD PARK, N.Y., Oct. 7, 2020 /PRNewswire/ --Aging-US recently published "From Causes of Aging to Death from COVID-19" by Blagosklonny et al.

Key Points: 
  • ORCHARD PARK, N.Y., Oct. 7, 2020 /PRNewswire/ --Aging-US recently published "From Causes of Aging to Death from COVID-19" by Blagosklonny et al.
  • The hyperfunction theory of quasi-programmed aging explains why COVID-19 vulnerability is an age-dependent syndrome, linking it to other age-related diseases.
  • This is because pre-existing conditions are manifestations of biological age, ultimately meaning that A. aging and B. diseases are two sides of the same coin.
  • The Blagosklonny Research Team goes on to highlight that an anti-aging intervention, such as rapamycin , may slow aging and age-related diseases, potentially decreasing COVID-19 vulnerability.